GeneDx Holdings Corp. Class A Common Stock (WGS)
SERVICES-HEALTH SERVICES
- Headquarters
- United States
- Employees
- 1,300
- Market Cap
- $2.0B
About GeneDx Holdings Corp. Class A Common Stock
GeneDx Holdings Corp focuses on genomics, creating the foundation for providing genomic information at scale and pioneering exome and genome sequencing for rare and ultra-rare genetic pediatric disorders. The company believes exome and genome testing will become the standard for diagnosing genetic disease, with the potential to transform healthcare from reactive to proactive. It aims to advance precision medicine by offering genetic diagnoses at the earliest moments, driving improved outcomes, and fueling discovery with genomic intelligence. Its operating segment mainly provides pediatric and rare disease diagnostics, focusing on whole exome and genome sequencing and, to a lesser extent, data and information services.
SentiSense also tracks daily options readings for GeneDx Holdings Corp. Class A Common Stock: IV rank, put/call percentile, 25-delta skew, open-interest walls, and unusually active contracts, each measured against the stock's own history. Sign in to view them.
GeneDx Holdings Corp. Class A Common Stock stock analysis, sentiment tracking, and market intelligence on SentiSense.